Search for: "Lilly v. Heard"
Results 61 - 80
of 149
Sort by Relevance
|
Sort by Date
9 Dec 2015, 2:30 pm
This morning the Court heard argument in Fisher v. [read post]
6 Oct 2015, 12:04 pm
The case is Hill v. [read post]
30 Jul 2015, 1:16 pm
That is precisely what happened in Fields v. [read post]
26 May 2015, 7:42 am
Among other things he heard a bang-up presentation on genomics and personalized (also known as “precision”) medicine from Paige Sensenbrenner. [read post]
25 May 2015, 1:28 am
In Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 the Supreme Court reversed the findings of the High Court and Court of Appeal. [read post]
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]
10 Mar 2015, 11:55 pm
As in Hammon v. [read post]
10 Mar 2015, 11:55 pm
As in Hammon v. [read post]
20 Feb 2015, 10:54 am
LILLIS, No. 13-0596 Set to be argued on March 24, 2015 GREATER HOUSTON PARTNERSHIP v. [read post]
20 Feb 2015, 10:54 am
LILLIS, No. 13-0596 Chosen for future argument by order issued February 20, 2015 GREATER HOUSTON PARTNERSHIP v. [read post]
31 Dec 2014, 7:01 am
Recently, in Dart Cherokee Basin Operating Co. v. [read post]
7 Dec 2014, 3:29 pm
Among the significant –- but, really, very-well indexed –- number of issues, the decision delves into novelty, inventive step, insufficiency by excessive claim breadth, added matter, and claim construction in light of the influential Actavis v Eli Lilly, another Arnoldian decision that the very same judge clarifies further in this ruling. [read post]
2 Dec 2014, 7:35 am
The judge recorded:counsel pointed out that I had held in Actavis v Lilly at [112] that, in principle, a limitation made to a claim to avoid an objection of lack of clarity could be relied on as aid to construction. [read post]
4 Nov 2014, 11:58 am
In a very unusual development in a case that promised to be very interesting and important both domestically and internationally, Apotex has filed a notice of discontinuance literally on the day before and figuratively on the steps into the Court in its appeal against Sanofi in the Supreme Court of Canada that was to have been heard earlier today in Apotex et al v. [read post]
22 Jul 2014, 2:29 am
The SPC Blog carries a hot-off-the-press piece from victorious law firm Powell Gilbert following judgment in Eli Lilly v Human Genome Science. [read post]
21 Jul 2014, 10:32 am
”Even here, however, we see signs that UK courts are trying to be more consistent with the EPO, and in the HGS v Lilly litigation, reading the decision of the Supreme Court in Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 (see IPKat here) it is possible discern in the judgment a desire to not only apply the jurisprudence of the EPO Boards of Appeal, but also to reach the same conclusion (of sufficiency of the claims) on the specific… [read post]
10 Jun 2014, 7:44 pm
In this post, guest contributor Paul England (Taylor Wessing LLP) explains the legal issues and their consequences:UKIPO -- a 'court' for the purposes of the Brussels I Regulation Some courts look like this ...With Actavis v Eli Lilly [noted on the IPKat here] still fresh in our minds, and amendments to the Brussels I Regulation (recast) progressing through the European Parliament in preparation for the Unified Patent Court, jurisdictional matters are a hot… [read post]
13 May 2014, 9:23 am
"All this is compliant with the GAT and Folien decisions and the Corte di Cassazione ruling, as well the UK decision in Joined cases Actavis Group hf v Eli Lilly & Company (USA) and Medis ehf v Eli Lilly & Company (USA) [here]. [read post]
15 Nov 2013, 11:34 am
Eli Lilly & Co. v. [read post]
6 Nov 2013, 9:35 pm
This referral follows three earlier referrals to the CJEU concerning the interpretation of the SPC Regulation in the cases of Actavis v Sanofi, Lilly v Human Genome Sciences and Georgetown University. [read post]
